X4 Pharmaceuticals, Inc Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
X4 Pharmaceuticals, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • X4 Pharmaceuticals, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.18M, a 109% decline year-over-year.
  • X4 Pharmaceuticals, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $9.21M.
  • X4 Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2023 was $6.43M.
  • X4 Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2022 was -$6.27M, a 75.5% decline from 2021.
  • X4 Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2021 was -$3.57M, a 69.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.43M +$12.7M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$6.27M -$2.7M -75.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$3.57M -$1.46M -69.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$2.11M -$1.01M -91% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
2019 -$1.1M +$3.1M +73.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$4.2M -$4.45M -1760% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-19
2017 $253K -$1.12M -81.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.37M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.